Red Blood Cells Frozen: A cryophylactic substance may be added to the Red Blood Cells for extended manufacturers' storage at −65 °C or colder, provided the manufacturer submits data considered by the Director, Center for Biologics Evaluation and Research, as adequately demonstrating through in vivo cell survival and other appropriate tests that the addition of the substance, the materials used and the processing methods results in a final product that meets the required standards of safety, purity, and potency for Red Blood Cells, and that the frozen product will maintain those properties for the prescribed dating period. Section 640.11 (a) and (b) do not apply while a cryophylactic substance is present.
21 CFR Part 640 · Additional Standards for Human Blood and Blood Products
§ 640.17 Modifications for specific products
Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.
Amendment history
Federal Register documents that created or amended this section.
- 38 FR 32089 20 Nov 1973
- 41 FR 18292 3 May 1976
- 49 FR 23834 8 Jun 1984
- 50 FR 4139 29 Jan 1985
- 55 FR 11013 26 Mar 1990
- 63 FR 16685 6 Apr 1998